Solara Active Pharma Sciences Cash Flow
- Market cap
- ₹3,120 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹466.34 – ₹874.40
In the year ended FY25, Solara Active Pharma Sciences generated ₹187 crore from operating activities, invested ₹125 crore and paid out ₹46.8 crore on financing activities. Net cash flow for the year was ₹15.6 crore. Free cash flow was ₹78 crore.
Solara Active Pharma Sciences cash flow statement
Financial years, newest first. Negative figures are cash outflows.
| Item | FY25 |
|---|---|
| Cash from operating activities | 187 |
| Cash from investing activities | -125 |
| Cash from financing activities | -46.8 |
| Net cash flow | 15.6 |
| Capital expenditure | 109 |
| Free cash flow | 78 |
Source: Company filings, in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Solara Active Pharma Sciences cash flow — frequently asked questions
What is Solara Active Pharma Sciences' operating cash flow?
Solara Active Pharma Sciences' cash flow from operating activities was ₹187 crore in the year ended FY25.
What is Solara Active Pharma Sciences' free cash flow?
Solara Active Pharma Sciences' free cash flow — operating cash flow minus capital expenditure — was ₹78 crore in FY25, after capital expenditure of ₹109 crore.
How much did Solara Active Pharma Sciences spend on investing activities?
Net cash used in investing activities was ₹125 crore in FY25. This covers capital expenditure, acquisitions and the purchase or sale of investments.
Same Data For Peers
Trade Solara Active Pharma Sciences With ATS
Track SOLARA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.